Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Roger Deaton"'
Publikováno v:
Epilepsia. 43:394-398
Summary: Purpose: Patients with drug-resistant epilepsy have a higher incidence of psychiatric problems and possibly greater intolerance to antiepileptic drugs (AEDs) than do other patients with epilepsy. Concern has been raised that γ-aminobutyric
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d2e487f10a3b65dd079245da51bc4165
https://doi.org/10.1046/j.1528-1157.2002.16000.x
https://doi.org/10.1046/j.1528-1157.2002.16000.x
Publikováno v:
Epilepsy Research. 42:123-132
The effects of tiagabine (TGB) on abilities and on adjustment and mood are as yet incompletely understood. These effects were compared with those of phenytoin (PHT) and carbamazepine (CBZ) in an add-on study. Patients included in the analysis were ad
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9e42bb47eca1db005827f58b4d1bac89
https://doi.org/10.1016/s0920-1211(00)00169-8
https://doi.org/10.1016/s0920-1211(00)00169-8
Autor:
Jordi Salas-Salvado, Christian Torp-Pedersen, Ian Caterson, Walmir Coutinho, Nick Finer, Luc Van Gaal, Aldo Maggioni, Arya Sharma, Wygenia Brisco, Roger Deaton, Gillian Shepherd, Philip James, SCOUT Investigators
Publikováno v:
European Heart Journal
Cardiovascular responses to weight management and sibutramine in high-risk subjects: an analysis from the SCOUT trial. AIMS: The Sibutramine Cardiovascular OUTcomes (SCOUT) trial is a randomized, double-blind comparison of sibutramine vs. placebo, in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______3351::ef80cdd0fe5dc755e7a971b5ca89202a
http://hdl.handle.net/20.500.11797/PC1695
http://hdl.handle.net/20.500.11797/PC1695
Publikováno v:
Epilepsia. 43(11)
Summary: Purpose: Acute pancreatitis has been associated with a number of medications, including valproate (VPA). Valproate-coincident pancreatitis is uncommon and is usually associated with other risk factors; however, the United States Food and Dru
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2a3cbc3e50c90c8c709731d7a8f21834
https://pubmed.ncbi.nlm.nih.gov/12423394
https://pubmed.ncbi.nlm.nih.gov/12423394
Publikováno v:
Epilepsy research. 41(1)
Changes in body weight were evaluated in 349 patients from a study comparing efficacy of add-on therapy with tiagabine (TGB), carbamazepine (CBZ) or phenytoin (PHT). TGB add-on therapy showed no significant weight changes when added to either PHT or
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ea113d4f462bc26e0235bf4f1e0a2f5d
https://pubmed.ncbi.nlm.nih.gov/10924865
https://pubmed.ncbi.nlm.nih.gov/10924865
Publikováno v:
Epilepsy research. 33(2-3)
We reviewed the clinical safety of tiagabine HCl (TGB), a selective CNS GABA uptake inhibitor, in nearly 3100 patients from 53 separate clinical trials. TGB was found to have no clinically important effect upon hepatic metabolic processes, serum conc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b1e4833bbb5cd33626f3795cecc7476a
https://pubmed.ncbi.nlm.nih.gov/10094434
https://pubmed.ncbi.nlm.nih.gov/10094434